← Back to Clinical Trials
Recruiting NCT06902584
NCT06902584 North American Comfilcon A Clinical Study
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT06902584 |
| Status | Recruiting |
| Phase | — |
| Sponsor | CooperVision International Limited (CVIL) |
| Condition | Astigmatism |
| Study Type | OBSERVATIONAL |
| Enrollment | 182 participants |
| Start Date | 2025-02-05 |
| Primary Completion | 2025-12 |
Trial Parameters
Condition Astigmatism
Sponsor CooperVision International Limited (CVIL)
Study Type OBSERVATIONAL
Phase N/A
Enrollment 182
Sex ALL
Min Age 8 Years
Max Age 75 Years
Start Date 2025-02-05
Completion 2025-12
All Conditions
Interventions
comfilcon A Sphere lenscomfilcon A Toric lenscomfilcon A Multifocal lens
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The main objective of this study is to demonstrate acceptable safety and effectiveness (performance) of comfilcon A Sphere, Toric, Multifocal, Toric Multifocal and Energys lenses, when used in the general population.
Eligibility Criteria
Inclusion Criteria: 1. Age 8 to 75 years (inclusive). 2. Current wearer of the Comfilcon A sphere, toric, multifocal, toric multifocal or Energys contact lens for at least 12 months. 3. At least occasional overnight wear in the last 12 months. Exclusion Criteria: 1\. Current participation in a contact lens or contact lens care product clinical trial.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology